Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10 | 60 | 0 | 30 | 70 |
| Receivables | 0 | 0 | 3 | 0 | 0 |
| Other current assets | 30 | 50 | 17 | 20 | 30 |
| TOTAL | $40 | $110 | $20 | $50 | $100 |
| Non-Current Assets | |||||
| PPE Net | N/A | 150 | 150 | 140 | 60 |
| Other Non-Current Assets | 200 | 210 | 210 | 220 | 400 |
| TOTAL | $200 | $360 | $360 | $360 | $460 |
| Total Assets | $300 | $370 | $290 | $320 | $360 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 20 | 10 | 40 | 0 |
| Accrued Expenses | 80 | 170 | 150 | 530 | 210 |
| Other current liabilities | 740 | 600 | 640 | 10 | 430 |
| TOTAL | $1,940 | $1,820 | $1,670 | $1,670 | $1,830 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,940 | $1,820 | $1,670 | $1,670 | $1,830 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 54,540 | N/A | N/A | N/A |
| Common Shares | 50 | 50 | 10 | 10 | 10 |
| Retained earnings | -30,310 | -30,120 | -29,770 | -29,240 | -28,770 |
| Other shareholders' equity | 10 | 10 | 10 | 20 | 10 |
| TOTAL | $-1,640 | $-1,450 | $-1,380 | $-1,340 | $-1,460 |
| Total Liabilities And Equity | $300 | $370 | $290 | $330 | $370 |